News from eli lilly and company A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 27, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly Provides Update on Evacetrapib Phase 3 Trial

Eli Lilly and Company (NYSE: LLY) has accepted the recommendation of the ACCELERATE study data monitoring committee to continue the Phase 3 trial...

Jul 23, 2015, 12:04 ET
NASCAR driver Ryan Reed

Lilly Diabetes and NASCAR XFINITY Series Driver Ryan Reed Want You to Think About Your Diabetes Pit Crew

 To emphasize the importance of a support system in diabetes management, Lilly Diabetes and NASCAR XFINITY Series driver Ryan Reed will kick...

Jul 23, 2015, 06:32 ET
Eli Lilly and Company logo.

Eli Lilly and Company Announces Expansion of San Diego Biotechnology Center

Eli Lilly and Company (NYSE: LLY) today revealed plans to expand the Lilly Biotechnology Center located in San Diego, Calif. The expansion will...

Jul 23, 2015, 06:25 ET
Eli Lilly and Company logo.

Lilly Reports Second-Quarter 2015 Results, Revises 2015 Financial Guidance

Eli Lilly and Company (NYSE: LLY) today announced financial results for the second quarter of 2015.   $ in millions, except...

Jul 22, 2015, 12:00 ET
Eli Lilly and Company logo.

New Study Shows Florbetapir F 18 Injection Scans Led to Change in Diagnosis and Management of Patients Being Evaluated for Cognitive Decline

Eli Lilly and Company (NYSE: LLY) and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, today announced new data showing that...

Jul 22, 2015, 07:00 ET
Eli Lilly and Company logo.

Data Using New Delayed-Start Methodology Suggested Benefit of Early Treatment with Solanezumab in Patients with Mild Alzheimer's Disease

Eli Lilly and Company (NYSE: LLY) today announced results suggesting the treatment effect of solanezumab was preserved within a pre-specified...

Jul 14, 2015, 15:00 ET
Eli Lilly and Company logo.

Lilly Diabetes Launches Android Version of Glucagon Mobile Application for Those Who Support People with Diabetes

News Highlights - Now for Android: Lilly Diabetes' Glucagon Mobile App to support #diabetes caregivers - Leverage the power of...

Jul 09, 2015, 13:55 ET
Eli Lilly and Company logo.

Lilly Statement on FDA Advisory Committee Review of Necitumumab

 The U.S. Food and Drug Administration's (FDA) Oncologic Drugs Advisory Committee (ODAC) met today to discuss the data supporting Eli Lilly and...

Jul 01, 2015, 13:30 ET
Eli Lilly and Company logo.

Lilly Confirms Date and Conference Call for Second-Quarter 2015 Financial Results Announcement

Eli Lilly and Company (NYSE: LLY) will announce its financial results for the second quarter of 2015 on Thursday, July 23, 2015. Lilly will also...

Jun 29, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly and Immunocore Announce Immunotherapy-based Clinical Trial Collaboration in Melanoma

 Eli Lilly and Company (NYSE: LLY) and Immunocore Limited today announced that they have entered into an immunotherapy-based clinical trial...

Jun 25, 2015, 09:00 ET
Diabetes Scholars Foundation.

Diabetes Scholars Foundation Announces 2015 Scholarship Recipients

Attending college is a critical milestone in the lives of many young people. But balancing college life and a full course load while keeping a...

Jun 25, 2015, 06:00 ET
Eli Lilly and Company logo.

UK Court Rules in Favor of Lilly in Alimta Vitamin Regimen Patent Lawsuit

 Eli Lilly and Company (NYSE: LLY) today announced that the Court of Appeal has ruled that the Alimta® (pemetrexed disodium) vitamin...

Jun 19, 2015, 08:00 ET
Eli Lilly and Company logo.

CYRAMZA® (ramucirumab) Hepatocellular Carcinoma Data Published by The Lancet Oncology

 Eli Lilly and Company (NYSE: LLY) announced that The Lancet Oncology has published results of the Phase III REACH trial that evaluated...

Jun 17, 2015, 12:00 ET
Eli Lilly and Company logo

Lilly's investigational medicine for prevention of migraine met primary endpoint in a Phase 2b study

 Eli Lilly and Company (NYSE: LLY) announced today that its investigational medicine for prevention of migraine (LY2951742, a CGRP neutralizing...

Jun 17, 2015, 08:01 ET
Eli Lilly and Company logo.

Eli Lilly and Company Enters Into Strategic Partnership with Sarah Cannon Research Institute to Develop Investigational Oncology Therapy

Eli Lilly and Company (NYSE: LLY) and Sarah Cannon Research Institute (SCRI) today announced a strategic partnership to co‑develop an...

Jun 17, 2015, 08:00 ET
Dana-Farber Cancer Institute Logo

Lilly and Dana-Farber Cancer Institute Announce Research Collaboration

 Eli Lilly and Company (NYSE: LLY) and Dana-Farber Cancer Institute today announced a multiyear collaboration to research new medicines under...

Jun 15, 2015, 16:01 ET
Eli Lilly and Company logo.

Lilly Declares Third-Quarter 2015 Dividend

The board of directors of Eli Lilly and Company (NYSE: LLY) has declared a dividend for the third quarter of 2015 of $0.50 per share on outstanding...

Jun 11, 2015, 14:00 ET
Eli Lilly and Company logo.

Lilly Announces Webcast to Discuss Ixekizumab Phase III Data

 Eli Lilly and Company (NYSE: LLY) will host a webcast on June 23 to discuss three pivotal Phase III studies investigating ixekizumab for the...

Jun 10, 2015, 12:04 ET
Beyond the Surface: Psoriasis Impact on Quality of Life

Studies Show Psoriasis Patients Achieved Significant Levels of Skin Clearance and Improved Quality of Life after 12 Weeks of Ixekizumab Treatment

 Eli Lilly and Company (NYSE: LLY) announced today that detailed results of two pivotal Phase III studies for ixekizumab were published by The...

Jun 10, 2015, 08:00 ET
Eli Lilly and Company logo.

Lilly and Incyte unveil detailed data on two pivotal studies of baricitinib in rheumatoid arthritis

 Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced that five abstracts featuring data from three clinical...